Product Information
CLINDA-TRETINOIN 1.2%-0.025% is a generic product labeled by Actavis Pharma, Inc., priced at $3.5818 per GM under NDC 00472179060. Its NADAC has been published 223 times since Sep 21, 2016.
Strength
12; .25 mg/g; mg/g
Manufacturer
Actavis Pharma, Inc.NDC
00472179060
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
CLINDAMYCIN PHOSPHATE; TRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA202564On Market Since
7/5/2016
Pharmacological Classes
Price Statistics
The NADAC for CLINDA-TRETINOIN 1.2%-0.025% has been published 223 times since Sep 21, 2016, and over the history we have for it it has declined 64.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5818 per GM |
|---|---|
| All-time high | $9.9987 (Oct 11, 2017) |
| All-time low | $3.4425 (Mar 18, 2026) |
| 52-week high | $6.9072 |
| 52-week low | $3.4425 |
| Median price | $6.9072 |
| Average price | $7.3455 |
| Largest weekly change | -41.5% (Apr 17, 2024) |
| Weeks tracked | 223 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLINDA-TRETINOIN 1.2%-0.025%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDA-TRETINOIN 1.2%-0.025%, manufactured by Actavis Pharma, Inc., is $3.5818 per GM (NDC 00472179060), effective Jun 24, 2026.
How has the price of CLINDA-TRETINOIN 1.2%-0.025% changed over time?
Over the history we have for it, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has declined 64.2%. It has been tracked across 223 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for CLINDA-TRETINOIN 1.2%-0.025%?
Since Sep 21, 2016, the NADAC for CLINDA-TRETINOIN 1.2%-0.025% has ranged from a low of $3.4425 (Mar 18, 2026) to a high of $9.9987 (Oct 11, 2017), with a median of $6.9072 per GM.
Are there cheaper alternatives to CLINDA-TRETINOIN 1.2%-0.025%?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CLINDA-TRETINOIN 1.2%-0.025%, but none are currently priced below it.
Who manufactures CLINDA-TRETINOIN 1.2%-0.025%?
CLINDA-TRETINOIN 1.2%-0.025% (NDC 00472179060) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification